Clinical Trial Update: Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

A completed Phase 1 trial comparing a test compound, Aczone 7.5% topical, and placebo for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Aczone 7.5% (dapsone)
• Test

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED